Abstract Ains-To investigate the incidence of functional hyposplenism in a group of patients who had undergone allogeneic bone marrow transplantation (BMT). Methods-Splenic function was assessed by counting the number of gluteraldehyde fixed red blood cells containing pits or indentations as examined by interference phase microscopy. Normal values are <2% whereas splenectomy patients have values of 25 to 40%. Results-Twenty eight BMT recipients (17 men, 11 women) were studied at varying periods post-transplant and the results compared with 20 healthy volunteers and 10 patients who had undergone splenectomy or had splenic atrophy because of haematological conditions. Ofthe 28 BMT recipients, one had undergone a prior splenectomy; ofthe remaining 27 patients, four (15%) had evidence of functional hyposplenism with between 5 0 and 34 0% pitted cells. Of these four patients, one had active extensive chronic graft versus host disease (GvHD) which has been previously reported to be associated with functional hyposplenism following transplantation. Only one of the four patients had peripheral blood red cell changes typical of hyposplenism. Conclusion-These results confirm that extensive chronic GvHD is associated with hyposplenism. Intermediate degrees of functional hyposplenism may also occur following BMT in the absence of chronic GvHD and in the absence of haematological features of hyposplenism on routine blood films. This may be of significance in mediating the susceptibility to infection with encapsulating bacteria seen following allogeneic BMT. (J Clin Pathol 1995;48:257-259) 
Methods-Splenic function was assessed by counting the number of gluteraldehyde fixed red blood cells containing pits or indentations as examined by interference phase microscopy. Normal values are <2% whereas splenectomy patients have values of 25 to 40%. Results-Twenty eight BMT recipients (17 men, 11 women) were studied at varying periods post-transplant and the results compared with 20 healthy volunteers and 10 patients who had undergone splenectomy or had splenic atrophy because of haematological conditions. Ofthe 28 BMT recipients, one had undergone a prior splenectomy; ofthe remaining 27 patients, four (15%) had evidence of functional hyposplenism with between 5 0 and 34 0% pitted cells. Of these four patients, one had active extensive chronic graft versus host disease (GvHD) which has been previously reported to All patients underwent BMT for haematological malignancies or severe aplastic anaemia. The conditioning regimen consisted of cyclophosphamide 120 mg/kg and fractionated total body irradiation (12 Gy). Cyclosporin and methotrexate were administered for GvHD prophylaxis according to our previously pub- tion was further studied by counting the number of red cell pits according to the method of Corazza et al.8 A wet preparation of one drop of peripheral blood mixed with 05 ml 3% gluteraldahyde buffered to pH 7-4 was examined by interference phase contrast microscopy. One thousand red cells were examined to determine the percentage with such pits (normal <2%). All samples were processed and examined by a single observer (AG). The Mann-Whitney U test was used to compare results between the patient group and the control group.
Results
The patient group comprised 28 allogeneic BMT recipients (17 women and 11 men). The median age at BMT was 40 years (range 15-52 years). Median follow up was 25 months (range 10-85 months). The clinical details including diagnosis at BMT and incidence of acute and chronic GvHD are outlined in the table. Six patients developed grade I acute GvHD. Active extensive chronic GvHD was present in one patient (case 15) at the time of the study. One patient (case 2) had extensive chronic GvHD which was in clinical remission. Two patients had limited stage chronic GvHD (cases 25 and 27); case 27 subsequently developed bronchiolitis obliterans with organising pneumonia.
Although recurrent minor bacterial infections occurred in three patients, none had serious bacterial infection 100 days post-BMT. However, one patient at our centre died of pneumococcal septicaemia one year post-BMT, before the current study was undertaken.
The figure shows the distribution of pitted red cell counts in the study group compared with healthy volunteers and patients who had undergone a splenectomy. Twenty three BMT recipients had pitted red cell counts of <2% whereas five patients had results above normal. One patient from this group had previously had a splenectomy for staging of Hodgkin's Cuthbert, Iqbal, Gates, Toghill, Russell 258 l group.bmj.com on September 21, 2017 -Published by http://jcp.bmj.com/ Downloaded from disease (case 5) and was excluded from further analysis. Thus, four of 27 (15%) BMT recipients had evidence of functional hyposplenism. As a group, the BMT recipients had significantly higher pitted red cell counts than the normal controls (U=4 34; p<0001). During the study, only two BMT recipients had Howell-Jolly bodies detectable on peripheral blood films (case 5 (previous splenectomy) and case 15 (active extensive chronic GvHD)).
Discussion
The prevalence of both acute and chronic GvHD was low in the study group, which is consistent with our previously published experience.10 Functional asplenia was observed in the one patient who had active extensive chronic GvHD, consistent with the report by Kahls et al. 6 However, the technique used for assessing splenic hypofunction by measuring pitted red cell counts is more sensitive than detection of Howell-Jolly bodies on peripheral blood films. Thus, we were able to identify patients with normal blood films who had intermediate degrees of functional hyposplenism and who did not have active extensive chronic GvHD.
As this technique is very simple to perform, regular follow up samples can easily be organised. Therefore, prospective evaluation of splenic function in BMT recipients could be conducted. This data may be of value in determining which patients should be offered long term antibiotic prophylaxis against encapsulated bacteria. We are currently undertaking such a prospective study of the significance of splenic dysfunction in mediating the susceptibility to bacterial infection following BMT.
Our current policy is to recommend penicillin V prophylaxis to all patients for a minimum of two years following BMT. At one year, we recommend polyvalent pneumococcal and H influenzae type b vaccination. Patients who develop extensive GvHD are maintained on penicillin V prophylaxis, as antibody responses to vaccination are impaired. Assessment of splenic function at regular intervals could be of additional value in determining patients without chronic GvHD who may benefit from penicillin V prophylaxis for more than two years.
